{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:43:43Z","timestamp":1792511023735,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.eprac.2025.11.014","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:20:32Z","timestamp":1765988432000},"page":"558-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Hyperparathyroidism Associated With Elevated Coronary Artery Calcium Scores and Increased Cardiovascular Risk"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-4343","authenticated-orcid":false,"given":"Justin S.","family":"Bauzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Romero-Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Ramchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabashini K.","family":"Ramchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Siperstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.11.014_bib1","article-title":"Role of coronary artery calcium score in the primary prevention of cardiovascular disease","volume":"373","author":"Nasir","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eprac.2025.11.014_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamainternmed.2019.6607","article-title":"Assessment of cardiovascular diagnostic tests and procedures offered in executive screening programs at top-ranked cardiology hospitals","volume":"180","author":"Ge","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1046","key":"10.1016\/j.eprac.2025.11.014_bib3","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140594","article-title":"Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management","volume":"88","author":"Divakaran","year":"2015","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.eprac.2025.11.014_bib4","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.amjcard.2017.09.001","article-title":"Comparison of the coronary artery calcium score and number of calcified coronary plaques for predicting patient mortality risk","volume":"120","author":"Arnson","year":"2017","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.eprac.2025.11.014_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.eprac.2025.11.014_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13176","article-title":"Coronary artery calcium scoring: an evidence-based guide for primary care physicians","volume":"289","author":"Cheong","year":"2021","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcct.2017.02.010","article-title":"Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the society of cardiovascular computed tomography","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.eprac.2025.11.014_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117130","article-title":"Association between primary hyperparathyroidism and cardiovascular outcomes: a systematic review and meta-analysis","volume":"185","author":"Kong","year":"2024","journal-title":"Bone"},{"issue":"43","key":"10.1016\/j.eprac.2025.11.014_bib9","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.2174\/1381612824999201105165642","article-title":"Cardiovascular risk in patients with primary hyperparathyroidism","volume":"26","author":"Tournis","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.21037\/gs.2019.10.21","article-title":"Primary hyperparathyroidism and hypertension","volume":"9","author":"Fisher","year":"2020","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP.14.1.69","article-title":"Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism","volume":"14","author":"Cardenas","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2025.11.014_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.11.080","article-title":"Primary hyperparathyroidism predicts hypertension: results from the National inpatient sample","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.surg.2019.05.094","article-title":"Coronary artery disease is more severe in patients with primary hyperparathyroidism","volume":"167","author":"Koubaity","year":"2020","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.surg.2015.07.037","article-title":"A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism","volume":"159","author":"Dural","year":"2016","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10554-008-9369-2","article-title":"Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients","volume":"25","author":"Kepez","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.eprac.2025.11.014_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/VHRM.S128084","article-title":"Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism","volume":"13","author":"Mesquita","year":"2017","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4158\/EP.14.2.155","article-title":"Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"14","author":"Streeten","year":"2008","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2025.11.014_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010153","article-title":"Predictive value of coronary artery calcium score categories for coronary events versus strokes: impact of sex and race: MESA and DHS","volume":"13","author":"Mehta","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.eprac.2025.11.014_bib19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eprac.2025.11.014_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eprac.2025.11.014_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"4S","key":"10.1016\/j.eprac.2025.11.014_bib21","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"25","key":"10.1016\/j.eprac.2025.11.014_bib22","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.eprac.2025.11.014_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/CIRCULATIONAHA.116.027034","article-title":"Value of progression of coronary artery calcification for risk prediction of coronary and cardiovascular events: result of the HNR study (Heinz Nixdorf Recall)","volume":"137","author":"Lehmann","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2016.03.022","article-title":"CAC score improves coronary and CV risk assessment above Statin indication by ESC and AHA\/ACC primary prevention guidelines","volume":"10","author":"Mahabadi","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.eprac.2025.11.014_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2013.08.1640","article-title":"Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic study of atherosclerosis)","volume":"63","author":"Bittencourt","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.eprac.2025.11.014_bib27","first-page":"548","article-title":"Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism","volume":"35","author":"Han","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.eprac.2025.11.014_bib28","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1210\/jc.2017-01080","article-title":"Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status","volume":"102","author":"Castellano","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.11.014_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.maturitas.2020.11.007","article-title":"Gender differences in the presentation, course and outcomes of primary hyperparathyroidism","volume":"145","author":"Dadon","year":"2021","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MNH.0b013e3283431921","article-title":"Estrogen, hormonal replacement therapy and cardiovascular disease","volume":"20","author":"Yang","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol Sex Differ"},{"issue":"6","key":"10.1016\/j.eprac.2025.11.014_bib32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamasurg.2019.3950","article-title":"Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension","volume":"155","author":"Graff-Baker","year":"2020","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib34","first-page":"240","article-title":"An evidence-based guide for coronary calcium scoring in asymptomatic patients without coronary heart disease","volume":"39","author":"Shah","year":"2012","journal-title":"Tex Heart Inst J"},{"issue":"8","key":"10.1016\/j.eprac.2025.11.014_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.31128\/AJGP-03-20-5277","article-title":"Coronary artery calcium in primary prevention","volume":"49","author":"Chua","year":"2020","journal-title":"Aust J Gen Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/0115701611280905231227045826","article-title":"Hyperparathyroidism and peripheral arterial disease","volume":"22","author":"Antignani","year":"2024","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"10.1016\/j.eprac.2025.11.014_bib37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldy042","article-title":"Mild primary hyperparathyroidism-to treat or not to treat?","volume":"129","author":"Hassan-Smith","year":"2019","journal-title":"Br Med Bull"},{"issue":"9","key":"10.1016\/j.eprac.2025.11.014_bib39","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s00268-018-4574-1","article-title":"Primary hyperparathyroidism is underdiagnosed and suboptimally treated in the clinical setting","volume":"42","author":"Enell","year":"2018","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.11.014_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.surg.2020.05.018","article-title":"Variation in surgical management of primary hyperparathyroidism in the US department of veterans affairs healthcare system: a 15-year observational study","volume":"168","author":"Alore","year":"2020","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eprac.2025.11.014_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.surg.2019.07.031","article-title":"Recognition of primary hyperparathyroidism: delayed time course from hypercalcemia to surgery","volume":"167","author":"Naples","year":"2020","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.eprac.2025.11.014_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48332","article-title":"Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism","volume":"5","author":"Lorenz","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eprac.2025.11.014_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2014.12.040","article-title":"Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions","volume":"239","author":"Alluri","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:16:43Z","timestamp":1776467803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25013229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1530891X25013229"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.11.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperparathyroidism Associated With Elevated Coronary Artery Calcium Scores and Increased Cardiovascular Risk","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}